Status:

COMPLETED

Antero-Posterior Knee Stability

Lead Sponsor:

David F. Scott, MD

Conditions:

Osteoarthritis

Total Knee Arthroplasty

Eligibility:

All Genders

21-80 years

Brief Summary

A retrospective one-time evaluation of total knee patients one year or more postoperative, to compare antero-posterior (AP) stability with the TELOS Stress device/stress x-rays and clinical outcomes. ...

Eligibility Criteria

Inclusion

  • Patients willing to sign the informed consent.
  • Patients able to comply with study requirements including stress x-rays and self-evaluations.
  • Male and non-pregnant females ages 21 - 80 years of age at the time of surgery.
  • Patients who have undergone a primary total knee replacement, are one year or greater postoperative, and are not having any evidence of failure of their implants.
  • Patients with a diagnosis of osteoarthritis (OA), traumatic arthritis (TA), or avascular necrosis (AVN).
  • Patients with intact collateral ligaments.
  • Range of motion within five degrees of full extension and a minimum of 120 degrees of flexion.

Exclusion

  • Patients with inflammatory arthritis.
  • Patients that are morbidly obese, body mass index (BMI) \> 40.
  • Patients that have had a high tibial osteotomy or femoral osteotomy.
  • Patients with neuromuscular or neurosensory deficiency, which would limit the ability to assess the performance of the device.
  • Patients with a systemic or metabolic disorder leading to progressive bone deterioration.
  • Patients that are immunologically compromised, or receiving chronic steroids (\>30 days), excluding inhalers.
  • Patients bone stock is compromised by disease or infection, which cannot provide adequate support and/or fixation to the prosthesis.
  • Patients with knee fusion to the affected joint.
  • Patients with an active or suspected latent infection in or about the knee joint.
  • Patients that are prisoners.

Key Trial Info

Start Date :

January 1 2016

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

December 1 2017

Estimated Enrollment :

100 Patients enrolled

Trial Details

Trial ID

NCT03387839

Start Date

January 1 2016

End Date

December 1 2017

Last Update

January 2 2018

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Spokane Joint Replacement Center

Spokane, Washington, United States, 99218